>Mercado europeo de pegamento de fibrina humana, por forma de envasado ( líquido , parche, otros), aplicación ( cirugía cardíaca , cirugía pulmonar, sangrado por quemaduras, cirugías vasculares, cirugías ortopédicas , laceraciones de hígado y bazo, neurocirugía, cirugía plástica, cirugía general, manejo de heridas, otros), canal de distribución (licitación directa y ventas minoristas), usuario final (hospitales, centros de atención ambulatoria, clínicas especializadas, otros), país (Alemania, Francia, Reino Unido, Italia, España, Rusia, Países Bajos, Suiza, Turquía, Austria, Bélgica, resto de Europa) Tendencias de la industria y pronóstico hasta 2029.
Análisis y perspectivas del mercado: mercado europeo de pegamento de fibrina humana
Se espera que el mercado europeo de pegamento de fibrina humana gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 9,0% en el período de pronóstico de 2022 a 2029, y se espera que alcance los USD 214,04 millones para 2029. El aumento en el desarrollo de productos y la creciente demanda de diagnóstico temprano son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico. Sin embargo, la estricta regulación está obstaculizando el crecimiento del mercado.
Los pegamentos de fibrina humana intervienen en el proceso de hemostasia y cicatrización de heridas. Un pegamento de fibrina humana (HFG) está hecho de dos componentes contenidos en viales separados: un concentrado liofilizado de proteínas de coagulación, principalmente fibrinógeno, factor XIII y fibronectina (el sellador), y trombina liofilizada (el catalizador), que se aplica a una herida o durante la cirugía para evitar la pérdida de sangre, crear un coágulo para la hemostasia, disminuir la estancia hospitalaria y dejar menos cicatrices.
Se prevé que el aumento de las aprobaciones de la FDA y la presencia de importantes actores del mercado aumenten el crecimiento del mercado. Las crecientes inversiones gubernamentales y la concienciación entre la población permiten que el mercado mejore el tratamiento. Sin embargo, se prevé que el creciente retiro de productos suponga un desafío para el mercado.
El informe de mercado de pegamento de fibrina humana proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de pegamento de fibrina humana en Europa
El mercado del pegamento de fibrina humana se clasifica en cuatro segmentos notables, según la forma del envase, la aplicación, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- On the basis of package form, the human fibrin glue market is segmented into liquid, patch, and others. In 2022, liquid segment is expected to dominate the Europe human fibrin glue market, due to increase in government spending on healthcare.
- On the basis of application, the human fibrin glue market is segmented into cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery, general surgery, wound management, and others. In 2022, wound management segment is expected to dominate the Europe human fibrin glue market, with the increasing surgical procedures in this region.
- On the basis of end user, the human fibrin glue market is segmented into hospitals, ambulatory care centre, specialty clinics, and others. In 2022, hospital segment is expected to dominate the market, due to growing demand of human fibrin glues.
- On the basis of distribution channel, the human fibrin glue market is segmented into direct tender and retail sales. In 2022, direct tender segment is expected to human fibrin glues market, with the presence of major market players.
Human Fibrin Glue Market Country Level Analysis
The human fibrin glue market is analyzed and market size information is provided on the basis of package form, application, end user and distribution channel.
The countries covered in the human fibrin glue market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, and Rest of Europe.
Germany is expected to dominate the Europe human fibrin glue market, due to growth of R & D in healthcare industry.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure are Boosting the Market Growth of Human Fibrin Glue
Human fibrin glue market also provides you with detailed market analysis for every country growth in Human fibrin glue industry with human fibrin glue sales, impact of advancement in the human fibrin glue technology and changes in regulatory scenarios with their support for the human fibrin glue market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Human Fibrin Glue Market Share Analysis
El panorama competitivo del mercado de pegamento de fibrina humana proporciona detalles por competidor. Los detalles incluidos son descripción general de la empresa, estados financieros de la empresa, ingresos generados, potencial de mercado, inversión en investigación y desarrollo, nuevas iniciativas de mercado, sitios e instalaciones de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, líneas de prueba de productos, aprobaciones de productos, patentes, amplitud y amplitud del producto, dominio de la aplicación, curva de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de pegamento de fibrina humana.
Algunas de las principales empresas que operan en el mercado europeo de pegamento de fibrina humana son Johnson & Johnson Services, Inc., Baxter, CSL Limited y Corza Health. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.
Muchos lanzamientos de productos y acuerdos también son iniciados por empresas de todo el mundo que también están acelerando el mercado del pegamento de fibrina humana.
Por ejemplo,
- En febrero de 2021, Corza Health adquirió y fusionó Surgical Specialties Corporation (“Surgical Specialties”) y el parche sellador de fibrina TachoSil (“TachoSil”) para crear una nueva empresa, Corza Medical. Esta fusión ha aumentado la cartera de productos y las ventas de la empresa.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de pegamento de fibrina humana, lo que también proporciona el beneficio para que la organización mejore su oferta de pegamento de fibrina humana.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PACKAGE FORM LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
6 REGULATORY ANALYSIS
6.1.1 REGULATION IN U.S.
6.1.2 REGULATION IN EUROPE
6.1.3 REGULATION IN AUSTRALIA
6.1.4 REGULATION IN CANADA
6.1.5 REGULATION IN CHINA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASING SURGICAL PROCEDURES
7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE
7.1.4 INCREASE IN THE GERIATRIC POPULATION
7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS
7.2 RESTRAINTS
7.2.1 STRINGENT RULES & REGULATORY
7.2.2 HIGH COST OF PRODUCTS
7.2.3 RISK OF VIRAL INFECTIONS
7.3 OPPORTUNITIES
7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS
7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES
7.3.3 RISING PLASTIC SURGERIES
7.4 CHALLENGES
7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE
7.4.2 LACK OF SKILLED PROFESSIONALS
7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19
8 IMPACT OF COVID-19 ON EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON SUPPLY CHAIN
8.3 IMPACT ON DEMAND
8.4 CONCLUSION
9 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM
9.1 OVERVIEW
9.2 LIQUID
9.2.1 1-2 ML
9.2.2 7-10 ML
9.2.3 3-4 ML
9.2.4 5-6 ML
9.3 PATCH
9.4 OTHERS
10 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 SPECIALTY CLINICS
10.4 AMBULATORY CARE CENTER
10.5 OTHERS
11 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 WOUND MANAGEMENT
12.3 BURN BLEEDING
12.4 PLASTIC SURGERY
12.5 GENERAL SURGERY
12.6 VASCULAR SURGERIES
12.7 LACERATIONS OF LIVER AND SPLEEN
12.8 CARDIAC SURGERY
12.9 PULMONARY SURGERY
12.1 ORTHOPEDIC SURGERIES
12.11 NEUROSURGERY
12.12 OTHERS
13 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 SWITZERLAND
13.1.7 RUSSIA
13.1.8 NETHERLANDS
13.1.9 TURKEY
13.1.10 BELGIUM
13.1.11 REST OF EUROPE
14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 CSL LIMITED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 JOHNSON & JOHNSON SERVICES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 BAXTER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 HUALAN BIOLOGICAL ENGINEERING, ING
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 SHANGHAI RAAS
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 CORZA HEALTH
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 MARQUEE BIOSURGICAL
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 2 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 4 EUROPE PATCH IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 7 EUROPE HOSPITALS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 8 EUROPE SPECIALTY CLINICS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 9 EUROPE AMBULATORY CARE CENTERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 10 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 11 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 12 EUROPE DIRECT TENDER IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 EUROPE RETAIL SALES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 15 EUROPE WOUND MANAGEMENT IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE BURN BLEEDING IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE PLASTIC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE GENERAL SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE VASCULAR SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE LACERATIONS OF LIVER AND SPLEEN IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE CARDIAC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 EUROPE PULMONARY SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE ORTHOPEDIC SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE NEUROSURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 27 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 28 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 29 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 31 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 33 GERMANY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 34 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 35 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 36 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 37 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 38 U.K. LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 39 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 40 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 41 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 42 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 43 FRANCE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 44 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 45 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 46 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 47 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 48 ITALY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 49 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 50 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 51 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 52 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 53 SPAIN LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 54 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 56 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 58 SWITZERLAND LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 59 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 61 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 62 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 63 RUSSIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 64 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 66 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 67 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 68 NETHERLANDS LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 69 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 71 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 73 TURKEY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 74 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 76 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 77 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 78 BELGIUM LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 79 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 80 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 81 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 82 REST OF EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 2 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR HUMAN FIBRIN GLUES ARE EXPECTED TO DRIVE THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 LIQUID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET IN 2022 AND 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
FIGURE 14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2021
FIGURE 15 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, CAGR (2022-2029)
FIGURE 17 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, LIFELINE CURVE
FIGURE 18 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2021
FIGURE 19 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, CAGR (2022-2029)
FIGURE 21 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, LIFELINE CURVE
FIGURE 22 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 23 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 25 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 26 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2021
FIGURE 27 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 29 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)
FIGURE 31 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)
FIGURE 32 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)
FIGURE 35 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
